terça-feira, 21 de abril de 2026
dev/financiero
SPYN/AN/AQQQN/AN/AEUR/USDN/AN/AGBP/USDN/AN/AUSD/MXNN/AN/ABTCN/AN/AETHN/AN/AOroN/AN/A
SPYN/AN/AQQQN/AN/AEUR/USDN/AN/AGBP/USDN/AN/AUSD/MXNN/AN/ABTCN/AN/AETHN/AN/AOroN/AN/A
Capa/
Yahoo Finance

Ocular Therapeutix (OCUL) Announces Additional Positive Data From the SOL-1 Phase 3 Superiority Trial of AXPAXLI

R
Redacción
Redação · anteayer
Leitura 2 min

Ler a nota completa em Yahoo Finance
Ocular Therapeutix (OCUL) Announces Additional Positive Data From the SOL-1 Phase 3 Superiority Trial of AXPAXLI · DevFinanciero